Search Results for: CAR-T cancer

Israeli leukemia treatment approved for UK children

Posted on September 9, 2018

The breakthrough CAR-T personalized leukemia therapy devised by Professor Zelig Eshhar of Israel’s Weizmann Institute (see here) is now available in the UK.  The National Health Service will fund Kymriah – the CAR-T treatment commercialized by Novartis. https://www.telegraph.co.uk/news/2018/09/04/nhs-fund-game-changing-personalised-cancer-drug/

Posted in Israel's Medical Achievements | Leave a comment

Lymphoma treatment approved

Posted on January 21, 2018

I reported previously (3rd Sep) on the US takeover of Israeli biotech Kite for $12 billion. The US FDA has now approved Kite’s Yescarta treatment for adults with relapsed or refractory large B-cell lymphoma. The treatment uses Israeli-developed CAR-T therapy … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment

Israeli-founded biotech exits for $11.9 billion

Posted on September 3, 2017

US giant Gilead has just bought Kite (a biotech founded by Israel’s Arie Belldegrun) for $11.9 billion.  Kite’s CAR-T technology was developed by Weizmann Institute’s Professor Zelig Eshhar. A patient’s own immune system T-cells are genetically engineered to attack tumors. … Continue reading →

Posted in Economy & Business | Leave a comment